Literature DB >> 18972295

Association of CCR5-delta32 mutation with reduced risk of nonatopic asthma in Slovenian children.

Vojko Berce1, Katja Repnik, Uros Potocnik.   

Abstract

Asthma is one of the most common chronic diseases of childhood. Asthma results from the interaction of several genes and environmental influences. Viral infections are common triggers of asthma attacks, especially in nonatopic asthmatics. CCR5 is a chemokine receptor involved in the immune response against a number of viruses. A 32 base pair deletion (delta32) in the CCR5 receptor gene causes loss of gene function and is associated with several chronic diseases due to the resulting altered immunity. The results of the association studies exploring the role of the CCR5 receptor gene in asthma pathogenesis are contradictory. We studied 111 children aged between 5 and 18 years with mild or moderate persistent asthma; 75 of them were atopic and 36 had nonatopic asthma. We carried out allergy and spirometry tests, a bronchoprovocation test with methacholine and performed measurement of exhaled nitric oxide and genotyping for CCR5-delta32 mutation. Compared with 365 nonatopic, nonasthmatic controls we found significantly lower CCR5-delta32 allelic frequency in nonatopic asthmatics (p = 0.016, OR 0.139, 95% CI 0.02 to 0.984) but not in atopic asthmatics. CCR5-delta32 mutation protects against nonatopic asthma. This association offers new insights into the pathogenesis of an important asthma phenotype and could serve as useful information for the future research of new asthma management strategies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18972295     DOI: 10.1080/02770900802386024

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  7 in total

1.  Polymorphisms in recent GWA identified asthma genes CA10, SGK493, and CTNNA3 are associated with disease severity and treatment response in childhood asthma.

Authors:  Petra Perin; Uroš Potočnik
Journal:  Immunogenetics       Date:  2014-01-10       Impact factor: 2.846

2.  Association between chemokine receptor 5 (CCR5) delta32 gene variant and atherosclerosis: a meta-analysis of 13 studies.

Authors:  Zhongwen Zhang; Ju Liu; Huanjun Wang; Hongxia Wu; Xuanmei Wu; Jianjun Dong; Lin Liao
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 3.  Personalized medicine: a pediatric perspective.

Authors:  Daniel Arnold; Bridgette L Jones
Journal:  Curr Allergy Asthma Rep       Date:  2009-11       Impact factor: 4.806

4.  Genome Wide Association Study to predict severe asthma exacerbations in children using random forests classifiers.

Authors:  Mousheng Xu; Kelan G Tantisira; Ann Wu; Augusto A Litonjua; Jen-hwa Chu; Blanca E Himes; Amy Damask; Scott T Weiss
Journal:  BMC Med Genet       Date:  2011-06-30       Impact factor: 2.103

5.  A Low Serum CCL4/MIP-1β Level May Predict a Severe Asthmatic Responsiveness to Mepolizumab.

Authors:  Maho Suzukawa; Nobuharu Ohshima; Hiroyuki Tashimo; Isao Asari; Nobuyuki Kobayashi; Shunsuke Shoji; Shigeto Tohma; Ken Ohta
Journal:  Intern Med       Date:  2020-07-21       Impact factor: 1.271

6.  CCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood CCR5+CD4+ T Cells Following Treatment With the Anti-CCR5 Antibody Leronlimab.

Authors:  Xiao L Chang; Helen L Wu; Gabriela M Webb; Meenakshi Tiwary; Colette Hughes; Jason S Reed; Joseph Hwang; Courtney Waytashek; Carla Boyle; Cleiton Pessoa; Andrew W Sylwester; David Morrow; Karina Belica; Miranda Fischer; Scott Kelly; Nader Pourhassan; Rachele M Bochart; Jeremy Smedley; Christopher P Recknor; Scott G Hansen; Jonah B Sacha
Journal:  Front Immunol       Date:  2021-11-19       Impact factor: 8.786

Review 7.  CCR5 as a Coreceptor for Human Immunodeficiency Virus and Simian Immunodeficiency Viruses: A Prototypic Love-Hate Affair.

Authors:  Anna J Jasinska; Ivona Pandrea; Cristian Apetrei
Journal:  Front Immunol       Date:  2022-01-27       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.